Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (31-40 of 192) with videos related to

Pageof 20
Sort By:
Scientific Reports|May 6, 2021
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLCMotohiro Tamiya, Akihiro Tamiya, Norio Okamoto, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2015
Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung DiseaseYuichiro Azuma, Motohiro Tamiya, Takayuki Shiroyama, et al.
Anticancer Research|November 2, 2010
Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesotheliomaHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Respirology (Carlton, Vic.)|April 17, 2013
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesionsMotohiro Tamiya, Norio Okamoto, Shinji Sasada, et al.
Internal Medicine (Tokyo, Japan)|March 23, 2011
Diagnostic factors of standard bronchoscopy for small (≤15 mm) peripheral pulmonary lesions: a multivariate analysisMotohiro Tamiya, Shinji Sasada, Masashi Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy--a case report]Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Cancer Medicine|June 26, 2024
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulantsTasuku Nakabori, Kei Kunimasa, Masaki Kawabata, et al.
Thoracic Cancer|November 20, 2022
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case reportKei Kunimasa, Takako Inoue, Yugo Kai, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2017
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancerYu Nishijima-Futami, Seigo Minami, Shinji Futami, et al.
Cancer Science|January 6, 2011
Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancerToyoaki Hida, Motohiro Tamiya, Makoto Nishio, et al.
Pageof 20

Showing results (31-40 of 192) with videos related to

Sort By:
Pageof 20
Scientific Reports|May 6, 2021
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLCMotohiro Tamiya, Akihiro Tamiya, Norio Okamoto, et al.
Internal Medicine (Tokyo, Japan)|November 17, 2015
Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung DiseaseYuichiro Azuma, Motohiro Tamiya, Takayuki Shiroyama, et al.
Anticancer Research|November 2, 2010
Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesotheliomaHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Respirology (Carlton, Vic.)|April 17, 2013
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesionsMotohiro Tamiya, Norio Okamoto, Shinji Sasada, et al.
Internal Medicine (Tokyo, Japan)|March 23, 2011
Diagnostic factors of standard bronchoscopy for small (≤15 mm) peripheral pulmonary lesions: a multivariate analysisMotohiro Tamiya, Shinji Sasada, Masashi Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy--a case report]Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Cancer Medicine|June 26, 2024
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulantsTasuku Nakabori, Kei Kunimasa, Masaki Kawabata, et al.
Thoracic Cancer|November 20, 2022
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case reportKei Kunimasa, Takako Inoue, Yugo Kai, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2017
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancerYu Nishijima-Futami, Seigo Minami, Shinji Futami, et al.
Cancer Science|January 6, 2011
Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancerToyoaki Hida, Motohiro Tamiya, Makoto Nishio, et al.
Pageof 20